The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer
Open accessAbstract
BACKGROUND: Patients with early gastric cancers that are limited to gastric mucosa or submucosa usually have an advanced loss of mucosal glandular tissue (glandular atrophy) and are at high risk for subsequent (metachronous) development of new gastric cancer. The long-term effects of treatment to eradicate Helicobacter pylori on histologic improvement and the prevention of metachronous gastric cancer remain unclear. METHODS: In this prospective, double-blind, placebo-controlled, randomized trial, we assigned 470 patients who had undergone endoscopic resection of early gastric cancer or high-grade adenoma to receive either H. pylori eradication therapy with antibiotics or placebo. Two primary outcomes were the incidence of metachronous gastric cancer detected on endoscopy performed at the 1-year follow-up or later and improvement from baseline in the grade of glandular atrophy in the gastric corpus lesser curvature at the 3-year follow-up. RESULTS: A total of 396 patients were included in the modified intention-to-treat analysis population (194 in the treatment group and 202 in placebo group). During a median follow-up of 5.9 years, metachronous gastric cancer developed in 14 patients (7.2%) in the treatment group and in 27 patients (13.4%) in the placebo group (hazard ratio in the treatment group, 0.50; 95% confidence interval, 0.26 to 0.94; P=0.03). Among the 327 patients in the subgroup that underwent histologic analysis, improvement from baseline in the atrophy grade at the gastric corpus lesser curvature was observed in 48.4% of the patients in the treatment group and in 15.0% of those in the placebo group (P<0.001). There were no serious adverse events; mild adverse events were more common in the treatment group (42.0% vs. 10.2%, P<0.001). CONCLUSIONS: Patients with early gastric cancer who received H. pylori treatment had lower rates of metachronous gastric cancer and more improvement from baseline in the grade of gastric corpus atrophy than patients who received placebo. (Funded by the National Cancer Center, South Korea; ClinicalTrials.gov number, NCT02407119 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Grading of Gastritis: The Updated Sydney System
Dixon, M. F., Genta, R. M., Yardley, J. H., & Correa, P. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00001 · Cited by 5,185
Helicobacter pylori Infection and the Risk of Gastric Carcinoma
Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., & Sibley, R. K. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251603 · Cited by 3,894
Suerbaum, S., & Michetti, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020542 · Cited by 2,987
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312288 · Cited by 2,946
Japanese gastric cancer treatment guidelines 2014 (ver. 4)
Japanese Gastric Cancer Association (2017) · Gastric Cancer · doi:10.1007/s10120-016-0622-4 · Cited by 2,429
The Vienna classification of gastrointestinal epithelial neoplasia
Schlemper, R. J., Riddell, R. H., Kato, Y., Borchard, F., Cooper, H. S., Dawsey, S. M., Dixon, M. F., Fenoglio-Preiser, C. M., Fléjou, J.-F., Geboes, K., et al. (2000) · Gut · doi:10.1136/gut.47.2.251 · Cited by 2,138
Self-citationHelicobacter pylori Infection and Gastric Carcinoma among Japanese Americans in Hawaii
Nomura, A., Stemmermann, G. N., Chyou, P.-H., Kato, I., Perez-Perez, G. I., & Blaser, M. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251604 · Cited by 1,762
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
Chey, W. D., Leontiadis, G. I., Howden, C. W., & Moss, S. F. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.563 · Cited by 1,604
Wong, B. C.-Y., Lam, S. K., Wong, W. M., Chen, J. S., Zheng, T. T., Feng, R. E., Lai, K. C., Hu, W. H. C., Yuen, S. T., Leung, S. Y., et al. (2004) · JAMA · doi:10.1001/jama.291.2.187 · Cited by 1,435
Fukase, K., Kato, M., Kikuchi, S., Inoue, K., Uemura, N., Okamoto, S., Terao, S., Amagai, K., Hayashi, S., & Asaka, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61159-9 · Cited by 1,244
Lee, Y.-C., Chiang, T.-H., Chou, C.-K., Tu, Y.-K., Liao, W.-C., Wu, M.-S., & Graham, D. Y. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.028 · Cited by 1,013
Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology
Ajani, J. A., D'Amico, T. A., Almhanna, K., Bentrem, D. J., Chao, J., Das, P., Denlinger, C. S., Fanta, P., Farjah, F., Fuchs, C. S., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0137 · Cited by 930
Ford, A. C., Forman, D., Hunt, R. H., Yuan, Y., & Moayyedi, P. (2014) · BMJ · doi:10.1136/bmj.g3174 · Cited by 580
Effectiveness of the korean national cancer screening program in reducing gastric cancer mortality
Jun, J. K., Choi, K. S., Lee, H.-Y., Suh, M., Park, B., Song, S. H., Jung, K. W., Lee, C. W., Choi, I. J., Park, E.-C., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.029 · Cited by 570
Self-citationUemura, N., Mukai, T., Okamoto, S., Yamaguchi, S., Mashiba, H., Taniyama, K., Sasaki, N., Haruma, K., Sumii, K., & Kajiyama, G. (1997) · PubMed · Cited by 546
Ma, J.-L., Zhang, L., Brown, L. M., Li, J.-Y., Shen, L., Pan, K.-F., Liu, W.-D., Hu, Y., Han, Z.-X., Crystal-Mansour, S., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs003 · Cited by 457
Chiba, T., Marusawa, H., & Ushijima, T. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.009 · Cited by 381
Helicobacter pylori and Gastric Carcinogenesis
Tsuji, S., Tsujii, M., Sun, W.-H., Gunawan, E. S., Murata, H., Kawano, S., & Hori, M. (1997) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199700001-00030 · Cited by 327
Rokkas, T., Pistiolas, D., Sechopoulos, P., Robotis, I., & Margantinis, G. (2007) · Helicobacter · doi:10.1111/j.1523-5378.2007.00563.x · Cited by 230
Meningiomas and Gliomas in Juxtaposition: Casual or Causal Coexistence?
Matyja, E., Kuchna, I., Kroh, H., Mazurowski, W., & Zabek, M. (1995) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199501000-00005 · Cited by 211
Maehata, Y., Nakamura, S., Fujisawa, K., Esaki, M., Moriyama, T., Asano, K., Fuyuno, Y., Yamaguchi, K., Egashira, I., Kim, H., et al. (2012) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2011.08.030 · Cited by 197
Pan, K.-F., Zhang, L., Gerhard, M., Ma, J.-L., Liu, W.-D., Ulm, K., Wang, J.-X., Zhang, L., Zhang, Y., Bajbouj, M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309197 · Cited by 180
Clinical Practice Guidelines for Gastric Cancer in Korea: An Evidence-Based Approach
Lee, J. H., Kim, J. G., Jung, H.-K., Kim, J. H., Jeong, W. K., Jeon, T. J., Kim, J. M., Kim, Y. I., Ryu, K. W., Kong, S.-H., et al. (2014) · Journal of Gastric Cancer · doi:10.5230/jgc.2014.14.2.87 · Cited by 176
Self-citationEffects of Helicobacter pylori Treatment on Gastric Cancer Incidence and Mortality in Subgroups
Li, W.-Q., Ma, J.-L., Zhang, L., Brown, L. M., Li, J.-Y., Shen, L., Pan, K.-F., Liu, W.-D., Hu, Y., Han, Z.-X., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju116 · Cited by 167
Asada, K., Nakajima, T., Shimazu, T., Yamamichi, N., Maekita, T., Yokoi, C., Oda, I., Ando, T., Yoshida, T., Nanjo, S., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307094 · Cited by 167
Shimizu, N., Ikehara, Y., Inada, K.-I., Nakanishi, H., Tsukamoto, T., Nozaki, K., Kaminishi, M., Kuramoto, S., Sugiyama, A., Katsuyama, T., et al. (2000) · PubMed · Cited by 156
Choi, J., Kim, S. G., Yoon, H., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.09.057 · Cited by 155
Yoon, S. B., Park, J. M., Lim, C., Cho, Y. K., & Choi, M. (2014) · Helicobacter · doi:10.1111/hel.12146 · Cited by 141
Kong, Y., Yi, H.-G., Dai, J.-C., & Wei, M.-X. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i19.5903 · Cited by 122
Staging of intestinal‐ and diffuse‐type gastric cancers with the OLGA and OLGIM staging systems
Cho, S., Choi, I. J., Kook, M., Nam, B., Kim, C. G., Lee, J. Y., Ryu, K. W., & Kim, Y. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12515 · Cited by 95
Self-citationMurakami, K., Kodama, M., Nakagawa, Y., Mizukami, K., Okimoto, T., & Fujioka, T. (2012) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-012-0317-2 · Cited by 9
Cited by
Smyth, E. C., Nilsson, M., Grabsch, H. I., van Grieken, N. C., & Lordick, F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31288-5 · Cited by 4,803
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327745 · Cited by 1,533
Malfertheiner, P., Camargo, M. C., El-Omar, E., Liou, J.-M., Peek, R., Schulz, C., Smith, S. I., & Suerbaum, S. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00431-8 · Cited by 1,191
Pimentel-Nunes, P., Libânio, D., Marcos-Pinto, R., Areia, M., Leja, M., Esposito, G., Garrido, M., Kikuste, I., Megraud, F., Matysiak-Budnik, T., et al. (2019) · Endoscopy · doi:10.1055/a-0859-1883 · Cited by 993
Metadata
- Authors
- Choi, I. J., Kook, M.-C., Kim, Y.-I., Cho, S.-J., Lee, J. Y., Kim, C. G., Park, B., & Nam, B.-H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-03-22
- Volume
- 378
- Issue
- 12
- Pages
- 1085-1095
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2792256546
- Cited by
- 673
- References
- 32
- FWCI
- 74.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.